Scholars@Duke

Neutropenic risk, use of colony-stimulating factors, and impact on the relative dose intensity of administered chemotherapy.

Publication ,  Conference
Webb, WB; Wu, Y; Head, H; Singh, S; Lyman, GH
Published in: Journal of Clinical Oncology
May 20, 2010
Published version (DOI) Publisher Link

Duke Scholars

Gary Herbert Lyman
Author Gary Herbert Lyman Medicine, Medical Oncology

Published In

Journal of Clinical Oncology

DOI

10.1200/jco.2010.28.15_suppl.6088

EISSN

1527-7755

ISSN

0732-183X

Publication Date

May 20, 2010

Volume

28

Issue

15_suppl

Start / End Page

6088 / 6088

Publisher

American Society of Clinical Oncology (ASCO)

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3211 Oncology and carcinogenesis
  • 1112 Oncology and Carcinogenesis
  • 1103 Clinical Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Webb, W. B., Wu, Y., Head, H., Singh, S., & Lyman, G. H. (2010). Neutropenic risk, use of colony-stimulating factors, and impact on the relative dose intensity of administered chemotherapy. In Journal of Clinical Oncology (Vol. 28, pp. 6088–6088). American Society of Clinical Oncology (ASCO). https://doi.org/10.1200/jco.2010.28.15_suppl.6088
Webb, W. B., Y. Wu, H. Head, S. Singh, and G. H. Lyman. “Neutropenic risk, use of colony-stimulating factors, and impact on the relative dose intensity of administered chemotherapy.” In Journal of Clinical Oncology, 28:6088–6088. American Society of Clinical Oncology (ASCO), 2010. https://doi.org/10.1200/jco.2010.28.15_suppl.6088.
Webb WB, Wu Y, Head H, Singh S, Lyman GH. Neutropenic risk, use of colony-stimulating factors, and impact on the relative dose intensity of administered chemotherapy. In: Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2010. p. 6088–6088.
Webb, W. B., et al. “Neutropenic risk, use of colony-stimulating factors, and impact on the relative dose intensity of administered chemotherapy.” Journal of Clinical Oncology, vol. 28, no. 15_suppl, American Society of Clinical Oncology (ASCO), 2010, pp. 6088–6088. Crossref, doi:10.1200/jco.2010.28.15_suppl.6088.
Webb WB, Wu Y, Head H, Singh S, Lyman GH. Neutropenic risk, use of colony-stimulating factors, and impact on the relative dose intensity of administered chemotherapy. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2010. p. 6088–6088.

Published In

Journal of Clinical Oncology

DOI

10.1200/jco.2010.28.15_suppl.6088

EISSN

1527-7755

ISSN

0732-183X

Publication Date

May 20, 2010

Volume

28

Issue

15_suppl

Start / End Page

6088 / 6088

Publisher

American Society of Clinical Oncology (ASCO)

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3211 Oncology and carcinogenesis
  • 1112 Oncology and Carcinogenesis
  • 1103 Clinical Sciences